Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ati-450
2. Zunsemetinib [inn]
3. Ati450
4. Cdd450
5. Zunsemetinib [usan]
6. Cdd-450
7. Ax2vwg0zcr
8. (1(2h),4'-bipyridin)-2-one, 3-chloro-4-((3,5-difluoro-2-pyridinyl)methoxy)-2'-(2-(1-hydroxy-1-methylethyl)-4-pyrimidinyl)-5',6-dimethyl-, (-)-
9. (p)-3-chloro-4-((3,5-difluoropyridin-2-yl)methoxy)-2'-(2-(2-hydroxypropan-2-yl)pyrimidin-4-yl)-5',6-dimethyl-2h-(1,4'-bipyridin)-2-one
10. 1640282-42-3
11. Unii-ax2vwg0zcr
12. Zunsemetinib [usan:inn]
13. Ati 450
14. Ati 450 [who-dd]
15. Chembl3704901
16. Schembl16279876
17. Gtpl11681
18. Bdbm175242
19. Ex-a6292
20. Who 11983
21. Hy-139553
22. Cs-0204147
23. Us9115089, 49
24. 1639791-42-6
25. 3-chloro-4-[(3,5-difluoropyridin-2-yl)methoxy]-1-[2-[2-(2-hydroxypropan-2-yl)pyrimidin-4-yl]-5-methylpyridin-4-yl]-6-methylpyridin-2-one
| Molecular Weight | 513.9 g/mol |
|---|---|
| Molecular Formula | C25H22ClF2N5O3 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 101 |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 888 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
27
PharmaCompass offers a list of Zunsemetinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zunsemetinib manufacturer or Zunsemetinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zunsemetinib manufacturer or Zunsemetinib supplier.
PharmaCompass also assists you with knowing the Zunsemetinib API Price utilized in the formulation of products. Zunsemetinib API Price is not always fixed or binding as the Zunsemetinib Price is obtained through a variety of data sources. The Zunsemetinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ati 450 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ati 450, including repackagers and relabelers. The FDA regulates Ati 450 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ati 450 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ati 450 supplier is an individual or a company that provides Ati 450 active pharmaceutical ingredient (API) or Ati 450 finished formulations upon request. The Ati 450 suppliers may include Ati 450 API manufacturers, exporters, distributors and traders.
Ati 450 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ati 450 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ati 450 GMP manufacturer or Ati 450 GMP API supplier for your needs.
A Ati 450 CoA (Certificate of Analysis) is a formal document that attests to Ati 450's compliance with Ati 450 specifications and serves as a tool for batch-level quality control.
Ati 450 CoA mostly includes findings from lab analyses of a specific batch. For each Ati 450 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ati 450 may be tested according to a variety of international standards, such as European Pharmacopoeia (Ati 450 EP), Ati 450 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ati 450 USP).
